CVET logo

Covetrus, Inc. (CVET) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Covetrus, Inc. (CVET), Healthcare sektöründe faaliyet gösteriyor, son olarak 20.99$'dan işlem görüyor ve $0 piyasa değerine sahip. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 45/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 8 Şub 2026
45/100 AI Puanı Hacim 6M

Covetrus, Inc. (CVET) Sağlık ve Boru Hattı Genel Bakışı

CEOBenjamin Wolin
Çalışanlar4035
MerkezPortland, ME, US
Halka Arz Yılı2019
SektörHealthcare

Covetrus is a leading animal-health technology and services company, providing comprehensive solutions to veterinary practices worldwide. With a focus on technology-driven efficiency and a broad product portfolio, Covetrus empowers veterinary professionals to deliver superior care and enhance their business performance in the growing animal health market.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 8 Şub 2026

Yatırım Tezi

Covetrus presents a notable research candidate within the animal health sector, driven by the increasing demand for veterinary services and pet ownership globally. The company's comprehensive suite of products and technology solutions positions it as a key partner for veterinary practices. Key value drivers include expanding its proprietary product offerings, increasing adoption of its software solutions, and leveraging its distribution network to reach more customers. While financial data is limited due to its private status, Covetrus's focus on technology and value-added services should drive revenue growth and improved profitability. The company's commitment to supporting veterinary practices through innovative solutions makes it a strong contender in the evolving animal health landscape.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Covetrus operates as an animal-health technology and services company.
  • The company offers a wide range of animal-health consumable products, including pharmaceuticals, vaccines, and supplements.
  • Covetrus provides value-added solutions such as inventory management and e-commerce platforms.
  • The company offers practice management software and data-driven applications to enhance business health for veterinary practices.
  • Covetrus serves the companion-animal, equine, and large-animal markets across North America, Europe, and the Asia Pacific regions.

Rakipler & Benzerleri

Güçlü Yönler

  • Comprehensive product and service offerings.
  • Established distribution network.
  • Proprietary and Covetrus branded products.
  • Technology-driven solutions for veterinary practices.

Zayıflıklar

  • Reliance on third-party suppliers.
  • Negative profit margin.
  • High beta indicates higher volatility.
  • Taken private, limiting investor access and transparency.

Katalizörler

  • Ongoing: Expansion of proprietary product portfolio to increase margins.
  • Ongoing: Increased adoption of practice management software to drive recurring revenue.
  • Ongoing: Strategic partnerships to expand market reach and product offerings.

Riskler

  • Potential: Economic downturn impacting pet owner spending on veterinary care.
  • Potential: Increased competition from established and emerging players in the animal health market.
  • Potential: Changes in animal health regulations affecting product approvals and distribution.
  • Ongoing: Reliance on third-party suppliers for key products.

Büyüme Fırsatları

  • Expansion of Proprietary Product Portfolio: Covetrus has the opportunity to increase its profitability by developing and marketing its own branded products. The global market for animal health products is estimated to reach $50 billion by 2027. By focusing on innovative and high-margin products, Covetrus can differentiate itself from competitors and capture a larger share of this growing market. A strong pipeline of proprietary products will also enhance customer loyalty and create a more sustainable revenue stream.
  • Increased Adoption of Software Solutions: Covetrus offers a suite of practice management software and data-driven applications designed to improve efficiency and enhance business health for veterinary practices. The market for veterinary software is projected to reach $1 billion by 2028. By focusing on user-friendly design and seamless integration with existing systems, Covetrus can drive adoption of its software solutions and generate recurring revenue streams.
  • Leveraging Distribution Network: Covetrus has an established distribution network that reaches veterinary practices across North America, Europe, and the Asia Pacific. By optimizing its logistics and expanding its reach into underserved markets, Covetrus can increase its sales volume and market share. The company can also leverage its distribution network to introduce new products and services to its existing customer base.
  • Strategic Partnerships and Acquisitions: Covetrus can accelerate its growth by forming strategic partnerships with other companies in the animal health industry. These partnerships can provide access to new technologies, products, and markets. Covetrus can also pursue acquisitions of smaller companies to expand its product portfolio and geographic reach. Strategic partnerships and acquisitions can help Covetrus to strengthen its competitive position and drive long-term growth.
  • Focus on Value-Added Services: In addition to product distribution and software solutions, Covetrus offers a range of value-added services such as inventory management, e-commerce platforms, and continuing education. By expanding its offerings in these areas, Covetrus can strengthen its relationships with veterinary practices and generate additional revenue streams. A focus on providing comprehensive solutions will help Covetrus to differentiate itself from competitors and become a trusted partner for veterinary professionals.

Fırsatlar

  • Expansion into new geographic markets.
  • Development of new proprietary products and services.
  • Increased adoption of software solutions.
  • Strategic partnerships and acquisitions.

Tehditler

  • Competition from other distributors and technology providers.
  • Changes in animal health regulations.
  • Economic downturn affecting pet ownership and spending.
  • Disruptive technologies.

Rekabet Avantajları

  • Established distribution network across North America, Europe, and Asia Pacific.
  • Comprehensive suite of products and services for veterinary practices.
  • Proprietary and Covetrus branded products.
  • Practice management software and data-driven applications.

CVET Hakkında

Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. Though relatively young as a corporation, Covetrus was formed with the intent to revolutionize the animal health industry. The company operates as a global animal-health technology and services provider, offering a wide array of products and solutions to veterinary practices. These include animal-health consumable products, such as proprietary and Covetrus branded products, small and large equipment, laboratory products, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements. Beyond product distribution, Covetrus provides value-added solutions like inventory management, e-commerce platforms, and continuing education services. The company also offers practice management software, data-driven applications, and client communication tools designed to increase staff efficiency and improve business health for veterinary practitioners and animal-health clinics. Covetrus serves the companion-animal, equine, and large-animal markets across North America, Europe, and the Asia Pacific regions. As of October 13, 2022, Covetrus was taken private, marking a new chapter in its evolution.

Ne Yaparlar

  • Distributes animal-health consumable products.
  • Offers proprietary and Covetrus branded products.
  • Provides small and large equipment for veterinary practices.
  • Distributes branded and generic pharmaceuticals and vaccines.
  • Offers practice management software and data-driven applications.
  • Provides value-added solutions like inventory management and e-commerce.
  • Offers continuing education services for veterinary practitioners.

İş Modeli

  • Sales of animal-health consumable products to veterinary practices.
  • Subscription fees for practice management software and data-driven applications.
  • Service fees for value-added solutions such as inventory management and e-commerce.
  • Distribution of finished goods pharmacy and specialty pharmaceutical compounding products.

Sektör Bağlamı

The animal health industry is experiencing steady growth, driven by increasing pet ownership and rising expenditure on animal care. Technological advancements are playing a crucial role, with veterinary practices adopting digital solutions to improve efficiency and enhance patient care. Covetrus operates within this dynamic landscape, competing with other distributors and technology providers. The industry is characterized by consolidation, with larger players acquiring smaller companies to expand their product portfolios and geographic reach. Covetrus's focus on technology and value-added services positions it favorably to capitalize on these trends and gain market share.

Kilit Müşteriler

  • Veterinary practices and clinics.
  • Companion-animal market.
  • Equine market.
  • Large-animal market.
AI Güveni: 71% Güncellendi: 8 Şub 2026

Finansallar

Grafik & Bilgi

Covetrus, Inc. (CVET) hisse senedi fiyatı: $20.99 (+0.00, +0.00%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

CVET için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

CVET için Wall Street fiyat hedefi analizi.

MoonshotScore

45/100

Bu puan ne anlama geliyor?

MoonshotScore, CVET'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

CVET Healthcare Hisse Senedi SSS

CVET için değerlendirilmesi gereken temel faktörler nelerdir?

Covetrus, Inc. (CVET) şu anda yapay zeka skoru 45/100, düşük puanı gösteriyor. Temel güçlü yan: Comprehensive product and service offerings.. İzlenmesi gereken birincil risk: Potential: Economic downturn impacting pet owner spending on veterinary care.. Bu bir finansal tavsiye değildir.

CVET MoonshotScore'u nedir?

CVET şu anda MoonshotScore'da 45/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

CVET verileri ne sıklıkla güncellenir?

CVET fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler CVET hakkında ne diyor?

CVET için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

CVET'a yatırım yapmanın riskleri nelerdir?

CVET için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Economic downturn impacting pet owner spending on veterinary care.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

CVET'ın P/E oranı nedir?

CVET için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CVET'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

CVET aşırı değerli mi, yoksa düşük değerli mi?

Covetrus, Inc. (CVET)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

CVET'ın temettü verimi nedir?

Covetrus, Inc. (CVET) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Fiyat itibarıyla Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data is limited due to the company being private.
  • Stock data pending update.
Veri Kaynakları

Popüler Hisseler